Activation of TLR3 by poly(I:C) or by endogenous mRNA ligands, such as those released from necrotic cells [2], induces secretion of pro-inflammatory cytokines and chemokines, a finding that suggests that TLR3 agonists modulate disease outcome during infection-associated inflammation [3]. Here, TLR3 is linked to infection.